NASDAQ:NAKA KindlyMD Q2 2025 Earnings Report $9.17 +0.67 (+7.88%) As of 09/18/2026 04:00 PM Eastern ProfileEarnings HistoryForecast KindlyMD EPS ResultsActual EPS-$13.60Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AKindlyMD Revenue ResultsActual Revenue$0.41 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AKindlyMD Announcement DetailsQuarterQ2 2025Date8/5/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile KindlyMD Earnings HeadlinesReviewing KindlyMD (NASDAQ:NAKA) and Repay (NASDAQ:RPAY)September 12, 2026 | americanbankingnews.comNakamoto Reports Second Quarter 2026 Financial and Operating ResultsAugust 13, 2026 | businesswire.comThe Last Gold Bull Market?Former CIA and Pentagon official Jim Rickards says the current gold bull market could be its last. Investment demand for gold rose 84 percent last year, according to Kitco, and Rickards projects prices could climb toward 10,000 dollars within 12 months. Rickards has identified a 2 dollar gold stock tied to a September 30 catalyst that he believes is positioned for major gains as this trend accelerates.September 20 at 1:00 AM | Paradigm Press (Ad)Nakamoto Launches Intelligence 2027, a New Flagship Event for the AI EconomyAugust 12, 2026 | businesswire.comNasdaq-listed firm makes a drastic move to go all in on BitcoinJune 24, 2026 | thestreet.comClear Street Executes First Bitcoin Depositary Receipt Trade Through Prime Brokerage PlatformJune 23, 2026 | globenewswire.comSee More KindlyMD Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like KindlyMD? Sign up for Earnings360's daily newsletter to receive timely earnings updates on KindlyMD and other key companies, straight to your email. Email Address About KindlyMDKindlyMD (NASDAQ:NAKA) is a healthcare company focused on providing integrated care for patients with complex medical needs, including chronic pain and substance use disorders. Its care model combines primary care, behavioral health services and medication-assisted treatment, with an emphasis on coordinated, patient-centered treatment. The company has operated clinics in Utah and has also used telehealth and other technology-enabled services to expand access to care. KindlyMD’s services are designed to support patients through ongoing treatment and recovery rather than addressing individual medical issues in isolation. KindlyMD became a publicly traded company through a business combination involving Nakamoto Holdings, with its common stock trading on the Nasdaq under the symbol NAKA. The company’s operations and leadership may continue to evolve as it develops its healthcare platform and expands its reach.View KindlyMD ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles J.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. HousingThese 3 Stocks Sit at the Center of NVIDIA’s Cybersecurity PushGold Has Gone Sideways, But These 3 Stocks Haven’tLennar's Q3 Miss Hides a Stronger Operating Story Beneath the Housing SlumpAeluma’s Selloff Could Be Setting Up Its Next Big MoveBraze Beat Expectations—Now 2 SaaS Peers Are in Focus Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
